Fed Sparks Profit T...
Health Care: Drugs
Celldex Therapeutics Inc. (CLDX: NASDAQ)
$12.41 0.11 | 0.89%
05/24/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -59.12M | -44.80M | -2.53M | -36.52M |
| Operating Gains/Losses | -80.00K | -53.00K | -42.00K | -532.00K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | 126.00K | 154.00K | 220.00K | 1.28M |
| (Increase) Decrease in Inventories | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| (Decrease) Increase In Payables | 3.76M | 2.08M | -1.19M | -2.46M |
| (Decrease) Increase In Other Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Other Working Capital | 499.00K | -104.00K | -35.66M | 1.38M |
| Other Non-Cash Items | 2.52M | 2.65M | 3.53M | 2.71M |
| Net Cash From Continuing Operations | -49.78M | -35.66M | -30.37M | -29.87M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -49.78M | -35.66M | -30.37M | -29.87M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 52.36M | 51.00M | 42.38M | 2.67M |
| Purchases of Property, Plant & Equipment | -303.00K | -509.00K | -2.10M | -528.00K |
| Acquisitions | 0.00 | 0.00 | 0.00 | 51.65M |
| Purchases of Short-Term Investments | -69.26M | -52.72M | -56.52M | -9.56M |
| Other Cash from Investing Activities | 218.00K | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -16.98M | -2.16M | -16.16M | 45.09M |
| Issuance of Debt | 0.00 | 5.00M | 10.00M | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 83.78M | 36.02M | 1.01M | 668.00K |
| Repayment of Long-Term Debt | 0.00 | -12.50M | -197.00K | -3.13M |
| Repurchase of Capital Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | -4.03M | -86.00K | 0.00 | 0.00 |
| Net Cash From Financing Activities | 79.76M | 28.43M | 10.82M | -2.46M |
| Effect of Exchange Rate Changes | 2.00K | -9.00K | 2.00K | -12.00K |
| Net Change in Cash & Cash Equivalents | 13.00M | -9.39M | -35.72M | 12.74M |
Portfolios with CLDX
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBreakout Stocks Of The Week...
- Userbio
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- Contributor7 Cancer Drug Stocks to Kno...
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Cheap Biotech Stocks Tha...
- User3rdwavemedia Portfolio 1
Latest CLDX Headlines from TheStreet
- 5 Stocks Poised for Breakouts 04.19.13 | 02:04 pm
- Celldex Presents CDX-1127 In Vitro Human Data Consistent With Strong Potency And Safety Profile At AACR 2013 04.08.13 | 01:04 pm
- Biotech Stock Mailbag: Celldex, TG Therapeutics, Sarepta 03.08.13 | 06:03 am
- Celldex Reports Fourth Quarter And Fiscal 2012 Financial Results 03.07.13 | 08:03 am
- Celldex Therapeutics To Report Fourth Quarter And Fiscal 2012 Financial Results And Host Corporate 2013 Strategic Outlook Call 02.28.13 | 08:02 am
- Positive Data From Celldex's Phase 1 Study Of CDX-301 Support Initiation Of Pilot Study In Hematopoietic Stem Cell Transplantation 02.14.13 | 08:02 am
- Celldex Therapeutics Announces Upcoming Presentation At Leerink Swann Global Healthcare Conference 2013 02.11.13 | 04:02 pm
- Celldex Announces Upcoming Oral Presentation On CDX-301 At The American Society For Blood And Marrow Transplantation 2013 BMT Tandem Meetings 02.11.13 | 09:02 am
- Celldex Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares 02.08.13 | 08:02 am
- Biotech Stock Mailbag: Dynavax, ImmunoCellular, Celldex and Medgenics 02.08.13 | 06:02 am
Press Releases for CLDX
- Celldex Therapeutics’ CDX-301 Safely Mobilizes Hematopoietic Cells In Phase 1 Study; Future Development Planned - Business Wire 12.11.12 | 08:12 am
- Final Data From Celldex Therapeutic’s CDX-011 Phase 2 Study In Metastatic Breast Cancer Supports Overall Survival Benefit In Patients With High GPNMB Expression - Business Wire 12.08.12 | 08:12 am
- Celldex Therapeutics Announces Upcoming Presentation At Oppenheimer Healthcare Conference - Business Wire 12.07.12 | 11:12 am
- Celldex Therapeutics Announces Upcoming Data Presentations On CDX-1127 And CDX-011 - Business Wire 12.04.12 | 10:12 am
- Celldex Therapeutics Announces Upcoming Presentation At The Deutsche Bank 2012 DbAccess BioFEST - Business Wire 11.30.12 | 08:11 am
- Celldex Therapeutics Announces Positive Three-Year Survival Data For Rindopepimut Phase 2 Clinical Program - Business Wire 11.15.12 | 05:11 pm
- Celldex Therapeutics Announces Upcoming Presentation At Lazard Capital Markets Healthcare Conference - Business Wire 11.09.12 | 09:11 am
- Celldex Announces Upcoming Data Presentation At The American Society Of Hematology 54th Annual Meeting And Exposition - Business Wire 11.05.12 | 04:11 pm
- Celldex Announces Upcoming Data Presentations At The Society For Neuro-Oncology 17th Annual Scientific Meeting And Education Day - Business Wire 11.05.12 | 07:11 am
- Celldex Reports Third Quarter 2012 Financial Results - Business Wire 11.01.12 | 08:11 am
Partner Headlines for CLDX
- Pre-Market Earnings Report for March 7, 2013 : CNQ, KR, BTE, SFD, NAV, JW/A, FGP, CIEN, EPL, PRIM, CMN, CLDX - NASDAQ 03.06.13 | 09:03 pm
- Anything Can Happen This Year For Celldex - Seeking Alpha 02.18.13 | 09:02 am
- Pre-Market Most Active for Feb 6, 2013 : ELN, QQQ, BAC, BBRY, ZNGA, NOK, GSK, VMED, KB, SNY, ARMH, CLDX - NASDAQ 02.06.13 | 01:02 pm
- Pre-Market Most Active for Dec 11, 2012 : AIG, BAC, HTZ, NOK, FB, HCA, GSK, SIRI, AAPL, URBN, QQQ, CLDX - NASDAQ 12.11.12 | 01:12 pm
- UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on Celldex Therapeutics - Benzinga 11.02.12 | 09:11 am
- A Gold Mine In Biotechnology: The Companies Poised To Benefit - Seeking Alpha 09.04.12 | 09:09 am
- Pre-Market Earnings Report for August 10, 2012 : BAM, JCP, HAR, CYD, HSFT, CLDX, HZNP, SCR, XIN, URRE, HSKA, DLGC - NASDAQ 08.09.12 | 08:08 pm
- Even In Clinical Studies, Big Potential For MRI-Guided Procedures - Seeking Alpha 06.28.12 | 09:06 am
- IsoRay: A Potential Small-Cap Bio-Pharma Multi-Bagger - Seeking Alpha 05.29.12 | 09:05 am
- Pre-Market Most Active for May 24, 2012 : BAC, PPL, EMC, NTAP, HPQ, MTGE, CLDX, TS, FB, MT, QQQ, VOD - NASDAQ 05.24.12 | 12:05 pm
